BEGIN:VCALENDAR VERSION:2.0 PRODID:-//BioCT - ECPv6.3.3.1//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:BioCT X-ORIGINAL-URL:https://bioct.org X-WR-CALDESC:Events for BioCT REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20190310T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20191103T060000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20190404T163000 DTEND;TZID=America/New_York:20190404T190000 DTSTAMP:20240329T025136 CREATED:20190326T195925Z LAST-MODIFIED:20190326T200035Z UID:1936-1554395400-1554404400@bioct.org SUMMARY:Predicting & Avoiding Roadblocks in Drug Discovery Through CRO Partnering DESCRIPTION:Presented by The Blavanik Fund for Innovation at Yale \nIn drug discovery\, you don’t know what you don’t know\, until it is too late. Working with drug discovery CRO partners can anticipate many of the dead ends on the drug discovery map. Assay development\, HTS screening\, hit & lead optimization\, PKPD\, in vivo POC\, formulation – hear our experts’ views on where the challenges lie and where new innovations can accelerate success. \nCo-sponsored by Genesis\nGenesis Biotechnology Group is a consortium of vertically integrated companies\, with a mission of improving patient’s care through cross linking our expertise\, dedication\, and vision in the fields of drug discovery\, personalized and tailored clinical diagnostics\, and through the development\, manufacturing and distribution of unique biotechnology-based products. \nThe event will begin at 4:30 and a light reception will follow. URL:https://bioct.org/event/predicting-avoiding-roadblocks-in-drug-discovery-through-cro-partnering/ LOCATION:The Analyan Center at Yale\, 300 Cedar Street\, New Haven\, CT\, 06519\, United States END:VEVENT END:VCALENDAR